В настоящем кратком докладе анализируются последние данные о распространенности употребления
табака в Европейском регионе ВОЗ, взятые из доклада о глобальной та...бачной эпидемии за 2017 г., рассматриваются предшествующие аналогичные доклады начиная с 2008 г, а также достижения в деле реализации комплекса мер MPOWER в Европейском регионе. В качестве обоснования используются фактические данные, собранные в «Сборнике аргументов для борьбы против табака». Оценивается прогресс, достигнутый в Европейском регионе ВОЗ в реализации Дорожной карты действий с целью усиления мер по осуществлению Рамочной конвенции ВОЗ по борьбе против табака в Европейском регионе на 2015–2025 гг. (далее – Дорожная карта), и протяженность дальнейшего пути к достижению конечной цели.
more
Eurosurveillance
Impact Factor 5.7
June 2015
www.eurosurveillance.org
Featuring a series of articles on HIV and STI epidemiology, prevention and control among MSM in Europe
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019 European Drug ...Report package.
Available in different languages: http://www.emcdda.europa.eu/publications/edr/trends-developments/2019_en
more
In 2018: 54% of new HIV infections were among key populations and their sexual partners, 40% decrease in new HIV infections since the peak in 1997, 37.9 million people living with HIV in the world, 1 700 000 children living with HIV (under 15 years)
C’est dans ce cadre que le PNLP a décidé de définir le cadre stratégique pour la période 2014 - 2018 en clarifiant ses orientations strategiques dans cet espace temporel. Ainsi il mettra à la disposition des acteurs et des partenaires un document technique de référence mais aussi de plaid...oyer.
more
Wenn es Ihnen nicht möglich ist, die Sprache der fremdsprachigen Person zu bestimmen, zeigen Sie ihr bitte diese Sprachtabelle. In alle Sprachen übersetzt ist «Sprechen Sie jeweilige Sprache?» Die Person wird mit dem Finger auf die Sprache zeigen, die sie kennt und entsprechend mit grosser Wahrs...cheinlichkeit versteht. Sollten Sie vorlesen müssen, können Sie die Aussprache der rechten Spalte entnehmen.
more
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention and control of multidrug-resistant tuberculosis and e...xtensively drug-resistant tuberculosis.
more
guidance for health managers, health workers, and activists
A lack of knowledge about the threat of vaccine-preventable diseases, risks and benefits of vaccines, mistrust of government and health workers, poor service delivery and alternative health or religious beliefs play a role in lower uptake of some vaccines. These challenges underscore the importance ...of early integration and investment in a thoughtful communication plan for immunization programmes. This World Health Organization (WHO) report presents communication guidance and specific considerations for countries that plan to introduce human papillomavirus (HPV) vaccine into their national immunisation programme as part of an effort to prevent cervical cancer.
more
There are two sets of charts. One set (14 charts) can be used in settings where blood cholesterol can be measured. The other set (14 charts) is for settings in which blood cholesterol cannot be measured. Both sets are available in colour and shades of black on a compact disc. Each chart can only be ...used in countries of the specific WHO epidemiological sub-region
more
Antimicrobial resistance (AMR) is an increasing worldwide public health problem with
important implications for the European Union (EU). When antibiotics become
ineffective, bacterial infections lead to increased morbidity, use of healthcare,
mortality and cost. Globally, estimates suggest that ...AMR leads to 700 000 deaths
per annum. For the EU, the European Centre for Disease Prevention and Control
(ECDC) has estimated that AMR currently causes 25 000 deaths annually and losses of
at least EUR 1.5 billion per annum in extra healthcare costs and productivity.
more
Training leaders in public health
IMDP 2016 Training Catalogue
Discussion paper initially prepared in April 2015 to facilitate feedback, and finalized after the
June 2015 meeting of WHO’s Strategic and Technical Advisory Group for TB (STAG-TB).